Compares two robotic systems for partial kidney removal in kidney cancer
Compares two robotic platforms for kidney tumor surgery in adults with renal carcinoma.
Plain-language title generated from the registry record
Registry title: Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)
Key facts
- Where
- Verona, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06290427, who can take part
Where in Italy
- Urology Unit, AOUI VeronaVerona, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Azienda Ospedaliera Universitaria Integrata Verona
- Trial code
- NCT06290427
- Record updated
- 3 January 2025
- Original description
The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:Read full original descriptionShow less
Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney
The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:
* DaVinci®; * Hugo®.
The questions it aims to answer are:
Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?
Participants will be invited to join one of these two experimental group:
1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.
Inclusion: patient aged between 18 and 90 years old; patient with localized kidney tumor suitable for partial nephrectomy; patient able to understand and sign the informed consent; patient compliance with the follow-up program.
Exclusion: patient who do not fall within the inclusion age range; patient not suitable for partial nephrectomy; patient unable to understand and sign the informed consent; patient unable to follow the monitoring program; patient refusal to participate to the study.